Marshall Wace North America’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$455K Sell
5,669
-116,411
-95% -$10M ﹤0.01% 1149
2021
Q2
$10.3M Buy
+122,080
New +$9.88M 0.04% 370
2021
Q1
Sell
-81,913
Closed -$6.58M 1537
2020
Q4
$6.58M Buy
+81,913
New +$5.96M 0.03% 472
2020
Q1
Sell
-36,754
Closed -$2.06M 1266
2019
Q4
$2.06M Buy
+36,754
New +$1.9M 0.01% 570
2018
Q1
Sell
-19,124
Closed -$1.17M 1454
2017
Q4
$1.17M Sell
19,124
-101,760
-84% -$6.48M 0.01% 959
2017
Q3
$6.65M Buy
+120,884
New +$6.14M 0.04% 467

Other funds holding CGNX

Marshall Wace North America's CGNX Position: Q3 2021 in Review

Marshall Wace North America reduced its Cognex (CGNX) stake by 95% in Q3 2021, selling an estimated $10M and leaving 5,669 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

Marshall Wace North America first reported a position in CGNX in Q3 2017 and has held it in 6 quarters since. The position peaked at $10.3M in Q2 2021. 535 funds tracked by Wall St. Rank hold CGNX as of Q3 2021.

  • Marshall Wace North America held 5,669 shares of Cognex worth $455K as of Q3 2021.
  • Marshall Wace North America sold 116,411 Cognex shares in Q3 2021, an estimated $10M.
  • Cognex made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1149 holding.
  • Marshall Wace North America first reported a position in Cognex in Q3 2017 and has held it in 6 quarters since.
  • Marshall Wace North America's Cognex position peaked at $10.3M in Q2 2021.
  • 535 funds tracked by Wall St. Rank held Cognex as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.